![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5852|2|3|217-234
ISSN: 1568-0053
Source: Current Drug Targets - Infectious Disorders, Vol.2, Iss.3, 2002-09, pp. : 217-234
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Yelle Jocelyn Sauvé Gilles Sayasith Khampoune
Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Structure and Function of HIV-1 Integrase
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. :